Products

Recombinant Mouse PD-L1 Protein, Fc Chimera

Product Information
Catalog#:  MK1008M
Product Name:  Recombinant Mouse PD-L1 Protein, Fc Chimera
Description:  Programmed death-ligand 1 (PD-L1) also known as cluster of differentiation 274 (CD274) or B7 homolog 1 (B7-H1), is a protein that in humans is encoded by the CD274 gene. PD-L1 is a 40 kDa type 1 transmembrane protein that has been speculated to play a major role in suppressing the immune system during particular events such as pregnancy, tissue allografts, autoimmune disease and other disease states such as hepatitis. Normally the immune system reacts to foreign antigens where there is some accumulation in the lymph nodes or spleen which triggers a proliferation of antigen-specific CD8+ T cell. The formation of PD-1 receptor / PD-L1 or B7.1 receptor /PD-L1 ligand complex transmits an inhibitory signal which reduces the proliferation of these CD8+ T cells at the lymph nodes and supplementary to that PD-1 is also able to control the accumulation of foreign antigen specific T cells in the lymph nodes through apoptosis which is further mediated by a lower regulation of the gene Bcl-2. PD-L1 binds to its receptor, PD-1, found on activated T cells, B cells, and myeloid cells, to modulate activation or inhibition.
Source:  HEK293 cells
Species:  Mouse
Tag:  Fc
Protein length:  Phe19-Thr238
Purity:  > 95% as determined by SDS-PAGE.
Storage:  Store under sterile conditions at -20 °C to -80 °C. Avoid repeated freeze-thaw cycles.
Reconstitution:  It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH2O or PBS up to 100 μg/mL.
Molecular Mass:  ~70.9 kDa, on SDS-PAGE under reducing conditions.
Stability:  Upon receiving, the product remains stable for 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C.
Endotoxin:  < 1 EU/μg of protein by gel clotting method.
Notes:  Research Use Only. Not for use in clinical procedures.
Menu
Contact Us
Subscribe

Enter your email here to subscribe